Related Experiment Video
Updated: Jan 16, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
The role of epigenetics in cancer: From pathways to the clinic
1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
Abstract:
Epigenetic changes are inherited but repairable genetic DNA modifications that affect gene expression regardless of the underlying sequence. Epigenetic abnormalities have been associated with a wide range of human diseases, including cancer. Malignancy can be caused by abnormal epigenetic changes that incorrectly activate oncogenes. Epigenetic marks are appealing therapeutic targets because they are reversible and susceptible to exogenous changes. Significant progress has been made in developing treatments that target epigenetic regulation in the past few years, with several pharmaceuticals being evaluated. this review describes the epigenetic drugs currently undergoing clinical trials. It also discusses the pros and cons of using them to treat cancer and the role of epigenetics in cancer diagnosis.
Insights
Epigenetic drugs, which modify gene expression without altering DNA sequence, are emerging as promising cancer treatments. This review covers current clinical trials, benefits, drawbacks, and diagnostic roles of these reversible epigenetic therapies.
Area of Science:
- Epigenetics and Molecular Biology
- Oncology
- Pharmacology
Background:
- Epigenetic modifications are heritable yet reversible DNA changes influencing gene expression.
- Aberrant epigenetic patterns are linked to various diseases, notably cancer, by misregulating oncogenes.
- The reversible nature of epigenetic marks makes them attractive targets for therapeutic intervention.
Purpose of the Study:
- To review current epigenetic drugs in clinical trials for cancer treatment.
- To discuss the advantages and disadvantages of epigenetic therapies in oncology.
- To explore the role of epigenetics in cancer diagnosis.
Main Methods:
- Literature review of epigenetic drugs currently in clinical trials.
- Analysis of the therapeutic potential, pros, and cons of epigenetic agents.
- Examination of epigenetic markers in cancer diagnostics.
Main Results:
- Several epigenetic drugs targeting cancer are progressing through clinical trials.
- Epigenetic therapies offer novel treatment avenues with potential benefits.
- Challenges and limitations associated with epigenetic drug use exist.
Conclusions:
- Epigenetic drugs represent a rapidly advancing field in cancer therapy.
- Understanding epigenetic mechanisms is crucial for both treatment and diagnosis.
- Further research is needed to optimize the use of epigenetic therapies in clinical practice.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

